Bicycle Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.About BCYC
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications.
CEOKevin Lee
CEOKevin Lee
Employees305
Employees305
HeadquartersCambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded2009
Founded2009
Employees305
Employees305
BCYC Key Statistics
Market cap480.29M
Market cap480.29M
Price-Earnings ratio-2.02
Price-Earnings ratio-2.02
Dividend yield—
Dividend yield—
Average volume245.88K
Average volume245.88K
High today$7.50
High today$7.50
Low today$6.75
Low today$6.75
Open price$7.33
Open price$7.33
Volume340.64K
Volume340.64K
52 Week high$17.04
52 Week high$17.04
52 Week low$6.03
52 Week low$6.03
Stock Snapshot
The current Bicycle Therapeutics(BCYC) stock price is $6.95, with a market capitalization of 480.29M. The stock trades at a price-to-earnings (P/E) ratio of -2.02.
On 2025-12-17, Bicycle Therapeutics(BCYC) stock traded between a low of $6.75 and a high of $7.50. Shares are currently priced at $6.95, which is +3.0% above the low and -7.3% below the high.
The Bicycle Therapeutics(BCYC)'s current trading volume is 340.64K, compared to an average daily volume of 245.88K.
In the last year, Bicycle Therapeutics(BCYC) shares hit a 52-week high of $17.04 and a 52-week low of $6.03.
In the last year, Bicycle Therapeutics(BCYC) shares hit a 52-week high of $17.04 and a 52-week low of $6.03.
Analyst ratings
69%
of 13 ratingsBuy
69.2%
Hold
30.8%
Sell
0%